… Extracorporeal photopheresis (ECP) has objective activity in the treatment of both acute
and chronic corticosteroid-refractory GvHD patients, has an excellent safety profile and is …

… Our results in chronic GVHD support previous reports of objective … extracorporeal
photopheresis. All of these results indicate activity of extracorporeal photopheresis in acute and …

… Six patients had acute graft-versus-host disease (… to extracorporeal photochemotherapy
(ECP). In 15 patients, 2 to 24 months after bone marrow transplantation (BMT), extensive chronic …

… Extracorporeal photopheresis (ECP), also known as extracorporeal photochemotherapy, …
The precise mechanism of ECP in the setting of acute and/or chronic GVHD is not clearly …

… Extracorporeal photopheresis (ECP) is an immunomodulatory alternative for treatment of
graft versus host disease (GVHD). The blood is then separated into its various components …

… Graft vs host disease (GVHD) is the most severe … Extracorporeal photopheresis (ECP)
has been introduced as … treatments, including extracorporeal photopheresis (ECP), anti-tumor …

… Extracorporeal photopheresis (ECP) is an effective treatment for both acute and chronic
graft-versus-host disease (GVHD) in children and adults. Despite the large use of this treatment, …

… Extracorporeal photopheresis is confirmed as an effective second-line treatment in both …
response in more than 80% of the patients and a long-term survival in at least 50% of the cases. …

… in strategies used to prevent and treat acute and chronic graft-versus-host disease (a/cGVHD…
Extracorporeal photopheresis (ECP) is a widely used cellular therapy currently approved by …

… Extracorporeal photopheresis (ECP) has been used for treatment of steroid-refractory graft
versus host disease (GVHD) with encouraging results. Although its exact mechanism of action …